HSP70 tumor-derived vaccine

heat shock protein 70 vaccine · University of Connecticut Health Center

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for HSP70 tumor-derived vaccine, covering 2008-10-08 to 2008-10-08. Get the full timeline:

Most recent: Clinical Trial Update: Vaccination Against High Risk Breast Cancer Using Tumor Derived Heat Shock Protein 70 [Phase 1, Phase 2]